DENOMINAZIONE FARMACO  (con link all'EPAR);PROCEDURA;ATC;PRINCIPIO ATTIVO;TITOLARE ;PARERE CHMP;DECISIONE COMMISSIONE;DATA GUUE;data CTS;  Tipologia;  AIC Farmaco;Numero UE  Confezioni ;PROVVEDIMENTO AIFA;;;DATA GURI;
ABASRIA  ;EMEA/H/C/2835;A10AE04 ;Insulin glargine;Eli Lilly Regional Operations GmbH.;giu-14;09-set-14;31-ott-14;10-nov-14;Generico / Equivalente / Biosimilare;043658;1/8;___;___;___;___;___
ABILIFY MAINTENA;EMEA/H/C/2755;N05AX12;Aripiprazole;Otsuka Pharmaceutical Europe Ltd.;set-13;15-nov-13;28-dic-13;13-gen-14;Prima autorizzazione;043143;01/04;86;29/01/2014;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_86NP.pdf;21/02/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2014_86_GU.pdf
ABRAXANE;EMEA/H/C/778;L01CD01 ;paclitaxel;Celgene Europe Limited;set-13;03-dic-13;31-gen-14;10-feb-14;Nuove confezioni;039399;02;176;27/02/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_n._176_2014.pdf;17/03/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina2014_176_GU.pdf
ABSEAMED;EMEA/H/C/727;B03XA01 ;epoetin alfa;Medice Arzneimittel Pütter GmbH & Co KG;NA;21-mar-14;25-apr-14;12-mag-14;Nuove confezioni;038494;53/55;621;23/06/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_621_del_2014.pdf;11/07/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_621_2014_GU.pdf
ACCOFIL ;EMEA/H/C/3956;L03AA02 ;Filgrastim;Accord Healthcare Limited;lug-14;18-set-14;31-ott-14;10-nov-14;Prima autorizzazione;043615;1/4;___;___;___;___;___
ACIDO COLICO FGK;EMEA/H/C/2081;A05AA03 ;cholic acid;FGK Representative Service GmbH;gen-14;04-apr-14;29-mag-14;09-giu-14;Prima autorizzazione;043363;01/02;___;___;In attesa che il titolare adempia agli obblighi previsti dalla Decisione Comunitaria (lettera del 16/06/14);___;___
ACIDO IBANDRONICO ACCORD;EMEA/H/C/2638;M05BA06;Acido ibandronico;Accord Healthcare Limited;set-12;19-nov-12;28-dic-12;09-gen-13;Generico / Equivalente / Biosimilare;042505;01/04;290;14/03/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina2013_290_14032013.pdf;28/03/13;http://www.agenziafarmaco.gov.it/sites/default/files/determina_290_2013_GU.pdf
ACIDO PARA-AMINO SALICILICO LUCANE;EMEA/H/C/2709;J04AA01 ;ra-aminosalicylic acid;Lucane Pharma;nov-13;07-apr-14;29-mag-14;09-giu-14;Prima autorizzazione;043376;01;___;___;___;___;___
ACIDO ZOLEDRONICO ACCORD;EMEA/H/C/2667;M05BA08 ;Acido zoledronico;Accord Healthcare Limited;nov-13;16-gen-14;28-feb-14;10-mar-14;Generico / Equivalente / Biosimilare;043198;01/03;334;01/04/2014;http://www.agenziafarmaco.gov.it/sites/default/files/determina_334NG.pdf;23/04/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2014_n._334_GU.pdf
ACIDO ZOLEDRONICO HOSPIRA;EMEA/H/C/2365;M05BA08;Acido zoledronico;Hospira UK Ltd;set-12;19-nov-12;28-dic-12;12-mar-13;Generico / Equivalente / Biosimilare;042486;01/04;367;05/04/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina_367_05042013.pdf;06/05/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_367-2013_GU.pdf
ACIDO ZOLEDRONICO MYLAN;EMEA/H/C/2482;M05BA08 ;Acido zoledronico;Mylan S.A.S ;NA;20-feb-14;28-mar-14;07/04/2014 e 12/05/2014;Nuove confezioni;042342;04;567;09/06/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_567_09.06.2014_acido_zole_myla.pdf;17/06/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_567-2014_GU.pdf
ACIDO ZOLEDRONICO TEVA GENERICS ;EMEA/H/C/2805;M05BA08 ;Acido zoledronico;Teva Generics B.V.;gen-14;27-mar-14;25-apr-14;12-mag-14;Generico / Equivalente / Biosimilare;043338;01/05;___;___;___;___;___
ACIDO ZOLEDRONICO TEVA PHARMA;EMEA/H/C/2437/IB/6;M05BA08 ;Acido zoledronico;Teva Pharma B.V.;ND;20-nov-13;28-dic-13;13-gen-14;Nuove confezioni;043144;05;___;___;___;___;___
ACTELSAR HCT;EMEA/H/C/2381;C09DA07;Telmisartan and diuretics;Actavis Group PTC ehf.;gen-13;13-mar-13;26-apr-13;14-mag-13;Generico / Equivalente / Biosimilare;042714;01/41;579;17/06/2013;http://www.agenziafarmaco.gov.it/sites/default/files/Determinazione_579-2013.pdf;05/07/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013-579_0.pdf
ADASUVE;EMEA/H/C/2400;N05AH01;Loxapina;Alexza UK Ltd;dic-12;20-feb-13;28-mar-13;10-apr-13;Prima autorizzazione;042696;01/02;___;___;In attesa che il titolare adempia agli obblighi previsti dalla Decisione Comunitaria (lettera del 22/04/13);___;___
ADASUVE;EMEA/H/C/2400;N05AH01;Loxapina;Alexza UK Ltd;NA;03-lug-14;25-lug-14;15-set-14;Nuove confezioni;042696;03/04;___;___;___;___;___
ADCETRIS;EMEA/H/C/2455;L01XC12;Brentuximab vedotin;Takeda Global Research and Development Centre (Europe) Ltd;lug-12;25-ott-12;30-nov-12;09-gen-13;Prima autorizzazione;042448;01;___;___;Farmaco in 648;___;___
ADEMPAS;EMEA/H/C/2737;C02KX05 ;riociguat;Bayer Pharma AG;gen-14;27-mar-14;25-apr-14;12-mag-14;Prima autorizzazione;043333;01/15;620;23/06/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_620_del_2014.pdf;11/07/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_620_2014_GU.pdf
AFINITOR;EMEA/H/C/1038;L01XE10;Everolimus;Novartis Europharm Limited;ott-12;18-dic-12;25-gen-13;14-mag-13;Nuove confezioni;039398;09/10;580;17/06/2013;http://www.agenziafarmaco.gov.it/sites/default/files/Determinazione_580-2013.pdf;05/07/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013-580_0.pdf
AMYVID;EMEA/H/C/2422;V09AX05 ;Florbetapir (18F);Eli Lilly Nederland B.V.;ott-12;14-gen-13;22-feb-13;10-apr-13;Prima autorizzazione;042650;01/04;888;14/10/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_AMYVID_888.pdf;28/10/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_888_GU.pdf
ANORO;EMEA/H/C/2751;R03AL03 ;umeclidinium bromide / vilanterol trifenatate;Glaxo Group Ltd;mar-14;08-mag-14;27-giu-14;01-lug-14;Prima autorizzazione;043438;01/03;881;18/08/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_881_del_18.07.2014.pdf;29/08/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina2014_881.pdf
ATOSIBAN SUN;EMEA/H/C/2329;G02CX01 ;Atosiban;Sun Pharmaceutical Industries Europe BV;mag-13;31-lug-13;30-ago-13;08-ott-13;Generico / Equivalente / Biosimilare;042916;01/02;995;13/11/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_995_2013.pdf;28/11/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_995_GU.pdf
AUBAGIO;EMEA/H/C/2514;L04AA31 ;Teriflunomide;Sanofi-aventis;giu-13;26-ago-13;27-set-13;08-ott-13;Prima autorizzazione;042921;01/05;794;24/07/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_794_del_24.07.2014.pdf;29/08/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina2014_794.pdf
BEMFOLA;EMEA/H/C/2615;G03GA05 ;follitropin alfa;FINOX Biotech AG;gen-14;27-mar-14;25-apr-14;09-giu-14;Generico / Equivalente / Biosimilare;043364;01/05;884;18/08/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_884_del_18.08.2014_0.pdf;29/08/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina2014_884.pdf
BETMIGA;EMEA/H/C/2388;G04BD12;Mirabegron;Astellas Pharma Europe BV;ott-12;20-dic-12;25-gen-13;12-mar-13;Prima autorizzazione;042647;01/14;369;05/04/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina_369_05042013.pdf;06/05/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_369-2013_GU.pdf
BETMIGA;EMEA/H/C/2388;G04BD12;Mirabegron;Astellas Pharma Europe BV;N/A;20-feb-14;28-mar-14;07-apr-14;Nuove confezioni;042647;15/18;391;16/04/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_391.pdf;29/04/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2014_391_GU.pdf
BEXSERO;EMEA/H/C/2333;J07AH09;Meningococcal group-B vaccine (rDNA, component, adsorbed);Novartis Vaccines and Diagnostics S.r.l.;nov-12;14-gen-13;22-feb-13;10-apr-13;Prima autorizzazione;042687;01/04;518;27/05/2013;http://www.agenziafarmaco.gov.it/sites/default/files/Determinazione_518-2013.pdf;14/06/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013-518.pdf
BINDREN;EMEA/H/C/2377;pending;Colestilan;Mitsubishi Pharma Europe Ltd.;ott-12;21-gen-13;22-feb-13;10-apr-13;Prima autorizzazione;042686;01/16;518;27/05/2013;http://www.agenziafarmaco.gov.it/sites/default/files/Determinazione_518-2013.pdf;14/06/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013-518.pdf
BINOCRIT;EMEA/H/C/725;B03XA01 ;epoetin alfa;Sandoz GmbH ;NA;21-mar-14;25-apr-14;12-mag-14;Nuove confezioni;038190;53/55;621;23/06/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_621_del_2014.pdf;11/07/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_621_2014_GU.pdf
BIRESP SPIROMAX;EMEA/H/C/3890;R03AK07 ;budesonide / formoterol;Teva Pharma B.V.;feb-14;28-apr-14;29-mag-14;09-giu-14;Prima autorizzazione;043365;01/06;___;___;___;___;___
BOSULIF;EMEA/H/C/2373;L01XE14;Bosutinib;Pfizer Limited;gen-13;27-mar-13;26-apr-13;06-giu-13;Prima autorizzazione;042735;01/04;613;01/07/2013;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013-613.pdf;12/07/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_613.pdf
BOSULIF;EMEA/H/C/2373/II/1;L01XE14;Bosutinib;Pfizer Limited;NA;23-giu-14;25-lug-14;15-set-14;Nuove confezioni;042735;05;1019;26/09/2014;http://www.agenziafarmaco.gov.it/sites/default/files/determina_NC_1019.pdf;14/10/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_n._1019-2014_GU.pdf
BRINTELLIX;EMEA/H/C/2717;N06AX26 ;vortioxetine;H. Lundbeck A/S;ott-13;18-dic-13;31-gen-14;10-feb-14;Prima autorizzazione;043187;01/36;180;27/02/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_n._180_2014.pdf;18/03/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina2014_180_GU.pdf
BUSULFAN FRESENIUS KABI  ;EMEA/H/C/2806;L01AB01 ;busulfan;Fresenius Kabi Oncology Plc.;lug-14;22-set-14;31-ott-14;10-nov-14;Generico / Equivalente / Biosimilare;043616;1;___;___;___;___;___
CAPECITABINA ACCORD;EMEA/H/C/2386;L01BC06 ;capecitabine;Accord Healthcare Limited ;NA;20-feb-14;28-mar-14;12-mag-14;Nuove confezioni;042640;19/27;621;23/06/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_621_del_2014.pdf;11/07/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_621_2014_GU.pdf
CAPECITABINA MEDAC;EMEA/H/C/2568;L01BC06;Capecitabina;Medac Gesellschaft für klinische Spezialpräparate mbH;set-12;19-nov-12;28-dic-12;09-gen-13;Generico / Equivalente / Biosimilare;042501;01/42;290;14/03/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina2013_290_14032013.pdf;28/03/13;http://www.agenziafarmaco.gov.it/sites/default/files/determina_290_2013_GU.pdf
CAPECITABINA SUN;EMEA/H/C/002050;L01BC06;Capecitabine;Sun Pharmaceutical Industries Europe BV;apr-13;21-giu-13;30-ago-13;27-set-13;Generico / Equivalente / Biosimilare;042823;1/2;886;14/10/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_NG_886.pdf;02/11/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_886_GU.pdf
CHOLIB;EMEA/H/C/2559;C10BA04 ;Simvastatin and fenofibrate;Abbott Healthcare Products Ltd;giu-13;26-ago-13;27-set-13;08-ott-13;Prima autorizzazione;042945;01/04;1049;20/11/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_1049_2013.pdf;06/12/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_1049_GU.pdf
CIALIS;EMEA/H/C/436;G04BE08 ;tadalafil;Eli Lilly Nederland B.V. ;NA;14-mar-14;25-apr-14;09-giu-14;Nuove confezioni;035672;10;___;___;___;___;___
CIMZIA;EMEA/H/C/1037/II/29;L04AB05 ;certolizumab pegol ;UCB Pharma S.A.;set-13;18-ott-13;29-nov-13;03-dic-13;Nuove confezioni;039539;03;169;27/02/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_n._169_2014.pdf;18/03/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina2014_169_GU.pdf
CIRCADIN;EMEA/H/C/695/N/45;N05CH01 ;Melatonina;RAD Neurim Pharmaceuticals EEC Limited;NA;29-giu-14;25-lug-14;15-set-14;Nuove confezioni;038264;04;1019;26/09/2014;http://www.agenziafarmaco.gov.it/sites/default/files/determina_NC_1019.pdf;14/10/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_n._1019-2014_GU.pdf
CLOPIDOGREL TEVA;EMEA/H/C/1053/R/29;B01AC04 ;Clopidogrel;Teva Pharma B.V. ;mar-14;16-mag-14;27-giu-14;01-lug-14;Nuove confezioni;041878;17;828;31/07/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_828_del_31.07.2014.pdf;29/08/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina2014_828.pdf
CLOPIDOGREL/ACIDO ACETILSALICILICO TEVA;EMEA/H/C/2272;B01AC30 ;clopidogrel / acetylsalicylic acid;Teva Pharma B.V.;giu-14;01-set-14;31-ott-14;10-nov-14;Generico / Equivalente / Biosimilare;043625;1/14;___;___;___;___;___
COMETRIQ;EMEA/H/C/2640;PENDING;cabozantinib;TMC Pharma Services Ltd.;dic-13;21-mar-14;25-apr-14;12-mag-14;Prima autorizzazione;043339;01/03;620;23/06/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_620_del_2014.pdf;11/07/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_620_2014_GU.pdf
CONSTELLA;EMEA/H/C/2490;A06AX04;Linaclotide;Almirall, SA;set-12;26-nov-12;28-dic-12;13-feb-13;Prima autorizzazione;042491;01/04;291;14/03/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina2013_291_14032013.pdf;29/03/13;http://www.agenziafarmaco.gov.it/sites/default/files/determina_291_2013_GU.pdf
DAKLINZA ;EMEA/H/C/3768;J05AX ;daclatasvir;Bristol-Myers Squibb Pharma EEIG;giu-14;22-ago-14;26-set-14;21-ott-14;Prima autorizzazione;043542;1/4;___;___;___;___;___
DEFITELIO;EMEA/H/C/2393;B01AX01 ;defibrotide;Gentium S.p.A.;lug-13;18-ott-13;29-nov-13;03-dic-13;Prima autorizzazione;043066;01;___;___;Farmaco in 648;___;___
DELTYBA;EMEA/H/C/2552;J04AK06 ;delamanid;Otsuka Novel Products GmbH;dic-13;28-apr-14;29-mag-14;09-giu-14;Prima autorizzazione;043367;01/03;871;13/08/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_871_del_13.08.2014_0.pdf;29/08/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina2014_871.pdf
DOCETAXEL KABI;EMEA/H/C/2325/II/2;L01CD02;Docetaxel;Fresenius Kabi Oncology Plc.;set-12;29-ott-12;28-dic-12;13-feb-13;Nuove confezioni;042285;05;___;___;Non applicabile (precedente provvedimento UP&R);___;___
DUORESP SPIROMAX ;A/H/C/2348;R03AK07 ;budesonide / formoterol;Teva Pharma B.V.;feb-14;28-apr-14;29-mag-14;09-giu-14;Prima autorizzazione;043366;01/06;___;___;___;___;___
EBILFUMIN;EMEA/H/C/3717;J05AH02 ;Oseltamivir;Actavis Group PTC ehf. ;mar-14;22-mag-14;27-giu-14;01-lug-14;Generico / Equivalente / Biosimilare;043439;01/06;799;25/07/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_799_del_25.07.2014.pdf;29/08/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina2014_799.pdf
EFAVIRENZ TEVA;EMEA/H/C/2352/IAin/10/G;J05AG03 ;Efavirenz;Teva Pharma B.V.;NA;04-lug-14;29-ago-14;15-set-14;Nuove confezioni;043172;11;1019;26/09/2014;http://www.agenziafarmaco.gov.it/sites/default/files/determina_NC_1019.pdf;14/10/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_n._1019-2014_GU.pdf
EFFICIB;EMEA/H/C/896/WS/559;A10BD07 ;Metformina e sitagliptin;Merck Sharp & Dohme Limited;NA;03-giu-14;25-lug-14;15-set-14;Nuove confezioni;038773;17/22;1019;26/09/2014;http://www.agenziafarmaco.gov.it/sites/default/files/determina_NC_1019.pdf;14/10/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_n._1019-2014_GU.pdf
ELIQUIS;EMEA/H/C/2148/X/4/G;B01AF02;Apixaban;Bristol-Myers Squibb/Pfizer EEIG;set-12;19-nov-12;28-dic-12;13-feb-13;Nuove confezioni;041225;06/12;292;14/03/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina2013_292_14032013_0.pdf;28/03/13;http://www.agenziafarmaco.gov.it/sites/default/files/GU292-2013sm.pdf
ELIQUIS;EMEA/H/C/2148/X/4/G;B01AF02;Apixaban;Bristol-Myers Squibb/Pfizer EEIG;set-12;19-nov-12;28-dic-12;12-mar-13;Nuove confezioni;041225;13;368;05/04/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina_368_05042013.pdf;06/05/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_368-2013_GU.pdf
ELIQUIS;EMEA/H/C/2148/X/4/G;B01AF02;Apixaban;Bristol-Myers Squibb/Pfizer EEIG;set-12;19-nov-12;28-dic-12;14-mag-13;Nuove confezioni;041225;06/12;590;21/06/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina_590.pdf;06/07/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013-590_0.pdf
ELIQUIS;EMEA/H/C/2148/II/14/G;B01AF02;Apixaban 2,5 mg;Bristol-Myers Squibb/Pfizer EEIG;giu-14;28-lug-14;29-ago-14;15-set-14;Nuove confezioni;041225;14/15;___;___;___;___;___
ENTYVIO;EMEA/H/C/2782/;L04AA33 ;Vedolizumab;Takeda Pharma A/S ;mar-14;22-mag-14;27-giu-14;01-lug-14;Prima autorizzazione;043442;01;1155;13/10/2014;http://www.agenziafarmaco.gov.it/sites/default/files/determina_NC1155_13.10.2014.pdf;24/10/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_1155_GU.pdf
ENVARSUS ;EMEA/H/C/2655;L04AD02 ;Tacrolimus;Chiesi Farmaceutici S.P.A.;mag-14;18-lug-14;29-ago-14;15-set-14;Generico / Equivalente / Biosimilare;043531;01/09;___;___;___;___;___
EPERZAN;EMEA/H/C/2735;A10BX13 ;albiglutide;GlaxoSmithKline Trading Services Limited ;gen-14;12-mar-14;25-apr-14;12-mag-14;Prima autorizzazione;043334;01/02;620;23/06/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_620_del_2014.pdf;11/07/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_620_2014_GU.pdf
ERIVEDGE;EMEA/H/C/002602;L01XX43;Vismodegib;Roche Registration Ltd;apr-13;12-lug-13;30-ago-13;08-ott-13;Prima autorizzazione;042881;01;164;17/02/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_n._164_2014.pdf;04/03/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2014_164_GU.pdf
ESMYA;EMEA/H/C/2041/IB/9;pending;Ulipristal;Gedeon Richter Plc.;N/A;29-ott-12;28-dic-12;13-feb-13;Nuove confezioni;042227;02;292;14/03/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina2013_292_14032013_0.pdf;28/03/13;http://www.agenziafarmaco.gov.it/sites/default/files/GU292-2013sm.pdf
EUCREAS;EMEA/H/C/807/WS/358;A10BD08 ;Metformin and vildagliptin;Novartis Europharm Limited;giu-13;26-lug-13;30-ago-13;08-ott-13;Nuove confezioni;038252;19/36;994;13/11/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_994_2013.pdf;28/11/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_994_GU.pdf
EVARREST;EMEA/H/C/2515;B02BC30 ;Human fibrinogen/Human thrombin;Omrix Biopharmaceuticals N.V.;giu-13;25-set-13;25-ott-13;06-nov-13;Prima autorizzazione;043011;01;1138;12/12/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_1138.PDF;27/12/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_1138_GU.pdf
EXELON ;EMEA/H/C/169;N06DA03;Rivastigmina;Novartis Europharm Ltd;NA;07-apr-14;29-mag-14;09-giu-14;Nuove confezioni;034078;31/34;___;___;In attesa che il titolare adempia agli obblighi previsti dalla Decisione Comunitaria (lettera del 16/06/14);___;___
EYLEA;EMEA/H/C/2392;S01LA05;Aflibercept;Bayer Pharma AG;set-12;22-nov-12;28-dic-12;13-feb-13;Prima autorizzazione;042510;01/02;291;14/03/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina2013_291_14032013.pdf;29/03/13;http://www.agenziafarmaco.gov.it/sites/default/files/determina_291_2013_GU.pdf
FLUENZ TETRA;EMEA/H/C/2617;J07BB03 ;Influenza Virus Type A, H1N1 / Influenza Virus Type A, H3N2 / Influenza Virus Type B (Victoria lineage) / Influenza Virus, Type B (Yamagata lineage);MedImmune, LLC;set-13;04-dic-13;31-gen-14;10-feb-14;Prima autorizzazione;043173;01;180;27/02/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_n._180_2014.pdf;18/03/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina2014_180_GU.pdf
FLUENZ TETRA;EMEA/H/C/2617;J07BB03 ;Influenza Virus Type A, H1N1 / Influenza Virus Type A, H3N2 / Influenza Virus Type B (Victoria lineage) / Influenza Virus, Type B (Yamagata lineage);MedImmune, LLC;lug-14;06-ago-14;26-set-14;21-ott-14;Nuove confezioni;043173;2;1337;11/11/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_1337_del_11.11.2014_0.pdf;___;___
FORXIGA;EMEA/H/C/2638;A10BX09;Dapagliflozin;Bristol Myers Squibb/AstraZeneca EEIG;set-12;12-nov-12;28-dic-12;13-feb-13;Prima autorizzazione;042494;01/10;291;14/03/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina2013_291_14032013.pdf;29/03/13;http://www.agenziafarmaco.gov.it/sites/default/files/determina_291_2013_GU.pdf
FYCOMPA;EMEA/H/C/2434/IB/03/G;N03AX22;Perampanel;Eisai Europe Limited;N/A;29-ott-12;30-nov-12;13-feb-13;Nuove confezioni;042581;17/23;292;14/03/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina2013_292_14032013_0.pdf;28/03/13;http://www.agenziafarmaco.gov.it/sites/default/files/GU292-2013sm.pdf
GANFORT;EMEA/H/C/668/PSUV/20 (PSU-10);S01ED51 ;bimatoprost / timolol;Allergan Pharmaceuticals Ireland, (514125);lug-13;04-ott-13;29-nov-13;03-dic-13;Nuove confezioni;037140;03/05;1141;12/12/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_1141.PDF;28/12/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_1141_GU.pdf
GAZYVARO ;EMEA/H/C/2799;L01 ;Obinutuzumab;Roche Registration Limited;mag-14;23-lug-14;29-ago-14;15-set-14;Prima autorizzazione;043533;01;1012;24/09/2014;http://www.agenziafarmaco.gov.it/sites/default/files/determina_NP_1012.pdf;14/10/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_n._1012-2014_GU.pdf
GILENYA;EMEA/H/C/2202/II/21;L04AA27 ;Fingolimod;Novartis Europharm Limited ;mar-14;23-mag-14;27-giu-14;01-lug-14;Nuove confezioni;040949;06;___;___;Farmaco in 648;;
GIOTRIF;EMEA/H/C/2280;L01XE13 ;Afatinib;Boehringer Ingelheim International GmbH;lug-13;25-set-13;25-ott-13;06-nov-13;Prima autorizzazione;043023;01/12;1138;12/12/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_1138.PDF;27/12/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_1138_GU.pdf
GLYBERA;EMEA/H/C/2145;C10AX10;Alipogene tiparvovec;uniQure biopharma B.V.;lug-12;25-ott-12;30-nov-12;differenti riunioni;Prima autorizzazione;042587;01;___;___;In attesa, dopo le decisioni del PRAC, che il titolare adempia agli obblighi previsti dalla Decisione Comunitaria (lettera del 12/06/13);___;___
GLYBERA;EMEA/H/C/2145;C10AX10;Alipogene tiparvovec;uniQure biopharma B.V.;lug-12;25-ott-12;30-nov-12;15-set-14;Prima autorizzazione;042587;01;___;___;___;___;___
GRASTOFIL;EMEA/H/C/2150;L03AA02 ;filgrastim;Apotex Europe B.V.;lug-13;18-ott-13;29-nov-13;03-dic-13;Generico / Equivalente / Biosimilare;043068;01/04;1140;12/12/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_1140.pdf;28/12/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_1140_GU.pdf
HEMANGIOL;EMEA/H/C/2621;C07AA05 ;propranolol;PIERRE FABRE DERMATOLOGIE;feb-14;23-apr-14;29-mag-14;09-giu-14;Prima autorizzazione;043368;01;___;___;In attesa che il titolare adempia agli obblighi previsti dalla Decisione Comunitaria (lettera del 16/06/14);___;___
HERCEPTIN;EMEA/H/C/278/X/0060;L01XC03 ;Trastuzumab;Roche Registration Limited;giu-13;26-ago-13;27-set-13;08-ott-13;Nuove confezioni;034949;02;1050;20/11/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_1050_2013.pdf;06/12/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_1050_GU.pdf
HEXACIMA;EMEA/H/C/2702 ;J07CA09;Diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B;Sanofi Pasteur S.A. / Sanofi Pasteur MSD, SNC;feb-13;17-apr-13;31-mag-13;04-lug-13;Prima autorizzazione;042816;01/07;690;26/07/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina_690.pdf;12/08/13;http://www.agenziafarmaco.gov.it/sites/default/files/determina_690_GU.pdf
HEXYON;EMEA/H/C/2796;J07CA09;Diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B;Sanofi Pasteur S.A. / Sanofi Pasteur MSD, SNC;feb-13;17-apr-13;31-mag-13;04-lug-13;Prima autorizzazione;042817;01/07;690;26/07/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina_690.pdf;12/08/13;http://www.agenziafarmaco.gov.it/sites/default/files/determina_690_GU.pdf
HIZENTRA;EMEA/H/C/2127;J06BA01 ;human normal immunoglobulin;CSL Behring GmbH;ott-13;18-dic-13;31-gen-14;10-mar-14;Nuove confezioni;041157;13/14;337;01/04/2014;http://www.agenziafarmaco.gov.it/sites/default/files/determina_337NC.pdf;23/04/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2014_n._337_GU.pdf
HUMALOG;EMEA/H/C/88/X/125;A10AB04 ;Insulin lispro;Eli Lilly Nederland B.V.;lug-14;30-set-14;31-ott-14;10-nov-14;Nuove confezioni;033637;39/42;___;___;___;___;___
HYQVIA;EMEA/H/C/2491;J06BA;Immunoglobulins, normal human;Baxter Innovations GmbH;mar-13;16-mag-13;28-giu-13;04-lug-13;Prima autorizzazione;042804;01/05;775;30/08/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina_HYQVIA_N.775.pdf;23/09/13;http://www.agenziafarmaco.gov.it/sites/default/files/determina_2013_775_gu.pdf
ICLUSIG;EMEA/H/C/2695;L01XE24;Ponatinib;ARIAD Pharma Ltd;apr-13;01-lug-13;30-ago-13;27-set-13;Prima autorizzazione;042853;01/04;___;___;Farmaco in 648;___;___
IMATINIB ACCORD;EMEA/H/C/002681;L01XE01;Imatinib;Accord Healthcare Limited;apr-13;01-lug-13;30-ago-13;27-set-13;Generico / Equivalente / Biosimilare;042867;01/14;886;14/10/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_NG_886.pdf;02/11/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_886_GU.pdf
IMATINIB ACTAVIS;EMEA/H/C/2594;L01XE01 ;Imatinib;Actavis Group PTC ehf;feb-13;17-apr-13;31-mag-13;06-giu-13;Generico / Equivalente / Biosimilare;042780;01/18;612;01/07/2013;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013-612.pdf;11/07/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_612.pdf
IMATINIB ACTAVIS;EMEA/H/C/2594/IB/4, EMEA/H/C/2594/X/3;L01XE01 ;Imatinib;Actavis Group PTC ehf;NA;12-giu-14;25-lug-14;15-set-14;Nuove confezioni;042780;19/23;1019;26/09/2014;http://www.agenziafarmaco.gov.it/sites/default/files/determina_NC_1019.pdf;14/10/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_n._1019-2014_GU.pdf
IMATINIB MEDAC;EMEA/H/C/2692;L01XE01 ;Imatinib;medac Gesellschaft für klinische Spezialpräparate mbH;ago-13;25-set-13;25-ott-13;06-nov-13;Generico / Equivalente / Biosimilare;043026;01/02;1139;12/12/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_1139.PDF;27/12/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_1139_GU.pdf
IMATINIB TEVA;EMEA/H/C/2585;L01XE01;Imatinib;Teva Pharma B.V.;ott-12;08-feb-13;22-feb-13;10-apr-13;Generico / Equivalente / Biosimilare;042644;01/40;516;27/05/2013;http://www.agenziafarmaco.gov.it/sites/default/files/Determinazione_516-2013.pdf;14/06/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013-516.pdf
IMNOVID (in precedenza Pomalidomide Celgene);EMEA/H/C/2682;L04AX06 ;Pomalidomide;Celgene Europe Limited;mag-13;05-ago-13;27-set-13;08-ott-13;Prima autorizzazione;042927;01/04;42;15/01/2014;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_n.42_%202014.pdf;04/02/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina%202014_42_GU.pdf
IMVANEX;EMEA/H/C/2596;J07BX;modified vaccinia ankara virus;Bavarian Nordic A/S;mag-13;31-lug-13;30-ago-13;08-ott-13;Prima autorizzazione;042944;01;993;13/11/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_993_2013.pdf;28/11/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_993_GU.pdf
INCRESYNC;EMEA/H/C/2178;A10BD09 ;Pioglitazone e alogliptin;Takeda Pharma A/S;lug-13;19-set-13;25-ott-13;06-nov-13;Prima autorizzazione;043030;01/36;1138;12/12/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_1138.PDF;27/12/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_1138_GU.pdf
INCRUSE;EMEA/H/C/2809;R03BB07 ;umeclidinium bromide;Glaxo Group Ltd;feb-14;28-apr-14;29-mag-14;09-giu-14;Prima autorizzazione;043374;01/03;___;___;___;___;___
INFANRIX HEXA;EMEA/H/C/296/IAin/160;J07CA09 ;diphtheria (d), tetanus (t), pertussis (acellular, component) (pa), hepatitis b (rdna) (hbv), poliomyelitis (inactivated) (ipv) and haemophilus influenzae type b (hib) conjugate vaccine (adsorbed);GlaxoSmithKline Biologicals S.A.;mag-14;30-set-14;31-ott-14;10-nov-14;Nuove confezioni;034960;21;___;___;___;___;___
INFLECTRA;EMEA/H/C/2778;L04AB02 ;Infliximab;Hospira UK Limited;giu-13;10-set-13;25-ott-13;06-nov-13;Generico / Equivalente / Biosimilare;043010;01/05;1220;31/12/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina_1220_2013.pdf;22/01/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_1220_GU.pdf
INLYTA;EMEA/H/C/2406/X/01;L01XE17 ;Axitinib;Pfizer Limited;giu-13;26-ago-13;27-set-13;08-ott-13;Nuove confezioni;042233;07/12;1050;20/11/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_1050_2013.pdf;06/12/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_1050_GU.pdf
INSUMAN;EMEA/H/C/201/X/91;A10AB01 ;human insulin;Sanofi-Aventis Deutschland GmbH;lug-13;19-set-13;25-ott-13;03-dic-13;Nuove confezioni;042204;202/203;___;___;In attesa che il titolare adempia agli obblighi previsti dalla Decisione Comunitaria (lettera del 09/12/13);___;___
INTELENCE;EMEA/H/C/900;J05AG04 ;Etravirine;Janssen-Cilag International NV;nov-12;06-mar-13;26-apr-13;14-mag-13;Nuove confezioni;038703;03;580;17/06/2013;http://www.agenziafarmaco.gov.it/sites/default/files/Determinazione_580-2013.pdf;05/07/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013-580_0.pdf
INVOKANA;EMEA/H/C/2649;A10BX11;canagliflozin;Janssen-Cilag International NV;set-13;15-nov-13;28-dic-13;13-gen-14;Prima autorizzazione;043145;01/08;86;29/01/2014;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_86NP.pdf;21/02/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2014_86_GU.pdf
IRBESARTAN / IDROCLOROTIAZIDE TEVA;EMEA/H/C/1112/IA/16/G;C09DA04 ;irbesartan / idroclorotiazide;Teva Pharma B.V.;N/A;13-dic-13;31-gen-14;10-feb-14;Nuove confezioni;041851;76/78;176;27/02/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_n._176_2014.pdf;17/03/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina2014_176_GU.pdf
ISENTRESS;EMEA/H/C/860;J05AX08;Raltegravir;Merck Sharp & Dohme Limited;nov-12;25-feb-13;28-mar-13;14-mag-13;Nuove confezioni;038312;03/04;580;17/06/2013;http://www.agenziafarmaco.gov.it/sites/default/files/Determinazione_580-2013.pdf;05/07/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013-580_0.pdf
ISENTRESS  ;EMEA/H/C/860/X/44/G;J05AX08;Raltegravir;Merck Sharp & Dohme Limited;giu-14;22-ago-14;26-set-14;21-ott-14;Nuove confezioni;038312;5;1337;11/11/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_1337_del_11.11.2014_0.pdf;___;___
IZBA;EMEA/H/C/2738;S01EE04 ;travoprost;Alcon Laboratories (UK) Ltd. ;dic-13;20-feb-14;28-mar-14;07-apr-14;Prima autorizzazione;043310;1/2;392;16/04/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_392.pdf;29/04/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2014_392_GU.pdf
JANUMET;EA/H/C/861/WS/559;A10BD07 ;Metformina e sitagliptin;Merck Sharp & Dohme Limited;NA;03-giu-14;25-lug-14;15-set-14;Nuove confezioni;038672;17/22;1019;26/09/2014;http://www.agenziafarmaco.gov.it/sites/default/files/determina_NC_1019.pdf;14/10/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_n._1019-2014_GU.pdf
JANUVIA;EMEA/H/C/722/WS/534;A10BH01 ;sitagliptin;Merck Sharp & Dohme Limited;mag-14;30-set-14;31-ott-14;10-nov-14;Nuove confezioni;037793;19/24;___;___;___;___;___
JARDIANCE;EMEA/H/C/2677;A10BX12 ;Empagliflozin;Boehringer Ingelheim International GmbH ;mar-14;22-mag-14;27-giu-14;01-lug-14;Prima autorizzazione;043443;01/18;881;18/08/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_881_del_18.07.2014.pdf;29/08/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina2014_881.pdf
JENTADUETO;EMEA/H/C/2279/IB/2/G;A10BD11;Metformin and linagliptin;Boehringer Ingelheim International GmbH;N/A;25-ott-12;30-nov-12;13-feb-13;Nuove confezioni;042203;29/34;292;14/03/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina2013_292_14032013_0.pdf;28/03/13;http://www.agenziafarmaco.gov.it/sites/default/files/GU292-2013sm.pdf
JETREA;EMEA/H/C/2381;pending;OCRIPLASMIN;ThromboGenics NV;gen-13;13-mar-13;26-apr-13;14-mag-13;Prima autorizzazione;042736;01;581;17/06/2013;http://www.agenziafarmaco.gov.it/sites/default/files/Determinazione_581-2013_0.pdf;05/07/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013-581_0.pdf
KADCYLA;EMEA/H/C/2389;L01XC14 ;Trastuzumab emtansine;Roche Registration Limited;set-13;15-nov-13;28-dic-13;13-gen-14;Prima autorizzazione;043092;01/02;170;27/02/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_n._170_2014.pdf;18/03/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina2014_170_GU.pdf
KEPPRA;EMEA/H/C/277/WS/242/G;N03AX14;Levetiracetam;UCB Pharma SA;set-12;18-dic-12;22-feb-13;13-feb-13;Nuove confezioni;035039;33/37;292;14/03/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina2013_292_14032013_0.pdf;28/03/13;http://www.agenziafarmaco.gov.it/sites/default/files/GU292-2013sm.pdf
KINERET;EMEA/H/C/363/X/42;L04AC03;Anakinra;Swedish Orphan Biovitrum AB (publ);set-13;15-nov-13;28-dic-13;13-gen-14;Nuove confezioni;035607;05/07;795;24/07/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_795_del_24.07.2014.pdf;29/08/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina2014_795.pdf
KRYSTEXXA;EMEA/H/C/2208;M04AX02;Pegloticase;Savient Pharma Ireland Ltd;ott-12;08-gen-13;22-feb-13;10-apr-13;Prima autorizzazione;042670;01;583;17/06/2013;http://www.agenziafarmaco.gov.it/sites/default/files/Determinazione_583-2013_0.pdf;06/07/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013-583_0.pdf
LATUDA;EMEA/H/C/2713;N05AE05 ;lurasidone;Takeda Pharma A/S;gen-14;21-mar-14;25-apr-14;12-mag-14;Prima autorizzazione;043335;01/21;620;23/06/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_620_del_2014.pdf;11/07/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_620_2014_GU.pdf
LAVENTAIR;EMEA/H/C/3754;R03AL03 ;umeclidinium bromide / vilanterol trifenatate;Glaxo Group Ltd ;mar-14;08-mag-14;27-giu-14;01-lug-14;Prima autorizzazione;043444;01/03;881;18/08/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_881_del_18.07.2014.pdf;29/08/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina2014_881.pdf
LEFLUNOMIDE MEDAC;EMEA/H/C/1227/X/12;L04AA13 ;Leflunomide;medac Gesellschaft für klinische Spezialpräparate mbH;mag-13;25-lug-13;30-ago-13;08-ott-13;Nuove confezioni;042083;10/13;994;13/11/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_994_2013.pdf;28/11/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_994_GU.pdf
LEMTRADA;EMEA/H/C/3718;PENDING;Alemtuzumab;Genzyme Therapeutics Ltd;giu-13;12-set-13;25-ott-13;06-nov-13;Prima autorizzazione;043027;01;885;18/08/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_885_del_18.08.2014_0.pdf;29/08/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina2014_885.pdf
LEVETIRACETAM HOSPIRA;EMEA/H/C/2783;N03AX14;levetiracetam;Hospira UK Limited;ott-13;08-gen-14;28-feb-14;10-feb-14;Generico / Equivalente / Biosimilare;043185;01/02;263;14/03/2014;http://www.agenziafarmaco.gov.it/sites/default/files/determina_263_Levetiracetam_Hospira.pdf;02/04/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina2014_263_GU.pdf
LEVODOPA CARBIDOPA ENTACAPONE SANDOZ;EMEA/H/C/2785;N04BA03;levodopa / carbidopa / entacapone;Orion Corporation;set-13;11-nov-13;28-dic-13;13-gen-14;Generico / Equivalente / Biosimilare;043152;01/38;87;29/01/2014;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_87NG.pdf;21/02/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2014_87_GU.pdf
LEVODOPA/CARBIDOPA/ENTACAPONE ORION;EMEA/H/C/2441;N04BA03;Levodopa, decarboxylase inhibitor and COMT inhibitor;Orion Corporation;apr-13;27-giu-13;30-ago-13;27-set-13;Nuove confezioni;042884;34/38;887;14/10/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_NC_887.pdf;29/10/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_887_GU.pdf
LIDOCAINE/ PRILOCAINE PLETHORA;EMEA/H/C/2693;N01BB20;lidocaine / prilocaine;Plethora Solutions Limited;set-13;15-nov-13;28-dic-13;13-gen-14;Prima autorizzazione;043149;01;86;29/01/2014;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_86NP.pdf;21/02/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2014_86_GU.pdf
LOJUXTA;EMEA/H/C/2578;C10AX12 ;Lomitapide;Aegerion Pharmaceuticals;mag-13;31-lug-13;30-ago-13;08-ott-13;Prima autorizzazione;042920;01/03;___;___;Farmaco in 648;___;___
LONQUEX;EMEA/H/C/2556;L03AA14;Lipegfilgrastim;Teva Pharma B.V.;mag-13;25-lug-13;30-ago-13;08-ott-13;Prima autorizzazione;042919;01/02;993;13/11/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_993_2013.pdf;28/11/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_993_GU.pdf
LUCENTIS;EMEA/H/C/715/II/40/G;S01LA04 ;ranibizumab;Novartis Europharm Limited ;mag-13;04-lug-13;---;10-mar-14;Nuove confezioni; 037608;03/04;569;09/06/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_569_09.06.2014_lucentis.pdf;17/06/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_569-2014_GU.pdf
LUMIGAN;EMEA/H/C/391/II/36/G;S01EE03;Bimatoprost;Allergan Pharmaceuticals Ireland;ott-12;19-nov-12;28-dic-12;13-feb-13;Nuove confezioni;035447;05/06;292;14/03/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina2013_292_14032013_0.pdf;28/03/13;http://www.agenziafarmaco.gov.it/sites/default/files/GU292-2013sm.pdf
LYXUMIA;EMEA/H/C/2445;pending;Lixisenatide;Sanofi-Aventis groupe;nov-12;01-feb-13;28-mar-13;10-apr-13;Prima autorizzazione;042657;01/05;518;27/05/2013;http://www.agenziafarmaco.gov.it/sites/default/files/Determinazione_518-2013.pdf;14/06/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013-518.pdf
MABTHERA;EMEA/H/C/165/X/83;L01XC02 ;Rituximab;Roche Registration Limited;gen-14;23-apr-14;25-apr-14;01-lug-14;Nuove confezioni;033315;03;___;___;Non applicabile (precedente provvedimento UP&R);;
MACI;EMEA/H/C/002522;M09AX02;Chondrocytes, autologous;Genzyme Europe B.V.;apr-13;27-giu-13;30-ago-13;27-set-13;Prima autorizzazione;042886;01;___;___;In attesa che il titolare adempia agli obblighi previsti dalla Decisione Comunitaria (lettera del 18/10/13);___;___
MARIXINO (in precedenza Maruxa);EMEA/H/C/2658;N06DX01;Memantine;Krka, d. d., Novo mesto;gen-13;29-apr-13;31-mag-13;06-giu-13;Generico / Equivalente / Biosimilare;042757;01/26;612;01/07/2013;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013-612.pdf;11/07/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_612.pdf
MEKINIST;EMEA/H/C/2643;L01XE25 ;Trametinib;Glaxo Group Ltd;apr-14;30-giu-14;25-lug-14;15-set-14;Prima autorizzazione;043524;01/06;1012;24/09/2014;http://www.agenziafarmaco.gov.it/sites/default/files/determina_NP_1012.pdf;14/10/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_n._1012-2014_GU.pdf
MEMANTINA  LEK;EMEA/H/C/2630;N06DX01;Memantina;Pharmathen S.A.;feb-13;22-apr-13;31-mag-13;06-giu-13;Generico / Equivalente / Biosimilare;042759;1/11;612;01/07/2013;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013-612.pdf;11/07/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_612.pdf
MEMANTINA  LEK;EMEA/H/C/2630;N06DX01;Memantina;Pharmathen S.A.;NA;03-giu-14;25-lug-14;15-set-14;Nuove confezioni;042759;12/15;1339;11/11/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_1339_del_11.11.2014_0.pdf;___;___
MEMANTINA ACCORD;EMEA/H/C/2766;N06DX01 ;memantina;Accord Healthcare Limited;set-13;04-dic-13;31-gen-14;10-feb-14;Generico / Equivalente / Biosimilare;043171;01/13;178;27/02/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_n._178_2014.pdf;17/03/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina2014_178_GU.pdf
MEMANTINA MERZ;EMEA/H/C/2711;N06DX01;Memantina;Merz Pharmaceuticals GmbH;set-12;22-nov-12;28-dic-12;13-feb-13;Generico / Equivalente / Biosimilare;042506;01/29;290;14/03/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina2013_290_14032013.pdf;28/03/13;http://www.agenziafarmaco.gov.it/sites/default/files/determina_290_2013_GU.pdf
MEMANTINA MYLAN;EMEA/H/C/2660;N06DX01;Memantina;Generics (UK) Limited;feb-13;22-apr-13;31-mag-13;06-giu-13;Generico / Equivalente / Biosimilare;042776;01/36;612;01/07/2013;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013-612.pdf;11/07/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_612.pdf
MEMANTINA RATIOPHARM;EMEA/H/C/2671;N06DX01;Memantina;ratiopharm GmbH;mar-13;13-giu-13;30-ago-13;04-lug-13;Generico / Equivalente / Biosimilare;042819;01/23;784;12/09/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina_784_2013.pdf;24/09/13;http://www.agenziafarmaco.gov.it/sites/default/files/determina_2013_784_gu.pdf
MIRVASO;EMEA/H/C/2642;PENDING;brimonidine;Galderma International ;dic-13;21-feb-14;28-mar-14;07-apr-14;Prima autorizzazione;043302;1/3;392;16/04/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_392.pdf;29/04/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2014_392_GU.pdf
NEMDATINE;EMEA/H/C/2680;N06DX01;Memantina;Actavis Group PTC ehf;feb-13;22-apr-13;31-mag-13;06-giu-13;Generico / Equivalente / Biosimilare;042783;01/20;612;01/07/2013;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013-612.pdf;11/07/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_612.pdf
NEURACEQ;EMEA/H/C/2553;V09AX06 ;Florbetaben (18F);Piramal Imaging GmbH ;dic-13;20-feb-14;28-mar-14;07-apr-14;Prima autorizzazione;043301;1;882;18/08/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_882_del_18.08.2014_0.pdf;29/08/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina2014_882.pdf
NEVANAC;EMEA/H/C/818;S01BC10 ;Nepafenac;Alcon Laboratories (UK) Ltd.;feb-13;03-mag-13;28-giu-13;27-set-13;Nuove confezioni;038813;02;887;14/10/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_NC_887.pdf;29/10/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_887_GU.pdf
NEXIUM CONTROL;EMEA/H/C/2618;A02BC05 ;Esomeprazole;AstraZeneca AB;giu-13;26-ago-13;27-set-13;08-ott-13;Prima autorizzazione;042922;01/02;1049;20/11/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_1049_2013.pdf;06/12/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_1049_GU.pdf
NEXOBRID;EMEA/H/C/2246;pending;Concentrate of proteolytic enzymes enriched in bromelain;Teva Pharma GmbH;set-12;18-dic-12;25-gen-13;12-mar-13;Prima autorizzazione;042539;01/02;369;05/04/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina_369_05042013.pdf;06/05/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_369-2013_GU.pdf
NOVOEIGHT;EMEA/H/C/2719;PENDING;turoctocog alfa;Novo Nordisk A/S;set-13;13-nov-13;28-dic-13;13-gen-14;Prima autorizzazione;043153;01/06;425;18/04/2014;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_425_NOVOEIGHT.pdf;19/05/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2014_425_GU.pdf
NOVORAPID;EMEA/H/C/258/;A10AB05 ;Insulin aspart;Novo Nordisk A/S;nov-13;10-gen-14;28-feb-14;10-mar-14;Nuove confezioni;034498;24;337;01/04/2014;http://www.agenziafarmaco.gov.it/sites/default/files/determina_337NC.pdf;23/04/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2014_n._337_GU.pdf
NOVOSEVEN;EMEA/H/C/74/II/72/G;B02BD08;Eptacog alfa (attivato);Novo Nordisk A/S;set-12;24-ott-12;30-nov-12;09-gen-13;Nuove confezioni;029447;08/11;292;14/03/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina2013_292_14032013_0.pdf;28/03/13;http://www.agenziafarmaco.gov.it/sites/default/files/GU292-2013sm.pdf
NOXAFIL ;EMEA/H/C/610/X/28;J02AC04 ;Posaconazole;Merck Sharp & Dohme Limited;feb-14;23-apr-14;29-mag-14;09-giu-14;Nuove confezioni;037059;02/03;___;___;___;___;___
NOXAFIL ;EMEA/H/C/610/X/33;J02AC04 ;Posaconazole;Merck Sharp & Dohme Limited;lug-14;18-set-14;31-ott-14;10-nov-14;Nuove confezioni;037059;4;___;___;___;___;___
NUEDEXTA;EMEA/H/C/002560;N07XX ;Dextromethorphan / quinidine;Jenson Pharmaceutical Services Ltd;apr-13;24-giu-13;30-ago-13;27-set-13;Prima autorizzazione;042824;01/3;___;___;In attesa che il titolare adempia agli obblighi previsti dalla Decisione Comunitaria (lettera del 18/10/13);___;___
NUWIQ ;EMEA/H/C/2813;B02BD02 ;Simoctocog alfa;Octapharma AB;mag-14;22-lug-14;29-ago-14;15-set-14;Prima autorizzazione;043534;01/04;1012;24/09/2014;http://www.agenziafarmaco.gov.it/sites/default/files/determina_NP_1012.pdf;14/10/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_n._1012-2014_GU.pdf
OLANZAPINA GELNMARK;EMEA/H/C/1085/R/19;N05AH03 ;Olanzapine;Glenmark Pharmaceuticals Europe Limited;giu-14;19-ago-14;26-set-14;21-ott-14;Nuove confezioni;043547;18/19;1337;11/11/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_1337_del_11.11.2014_0.pdf;___;___
OLYSIO;EMEA/H/C/2777;J05AE14 ;Simeprevir;Janssen-Cilag International NV ;mar-14;14-mag-14;27-giu-14;01-lug-14;Prima autorizzazione;043441;01/02;___;___;___;;
OPRYMEA;EMEA/H/C/941/X/14;N04BC05 ;pramipexole;Krka, d. d., Novo mesto;set-13;11-nov-13;28-dic-13;13-gen-14;Nuove confezioni;041010;26/45;88;29/01/2014;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_88NC.pdf;21/02/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2014_88_GU.pdf
OPTAFLU;EMEA/H/C/758;J07BB02;Influenza, purified antigen;Novartis;N/A;20-giu-13;---;04-lug-13;Nuove confezioni;038136;10/11;689;26/07/13;http://www.agenziafarmaco.gov.it/sites/default/files/determina_n.689_2013.pdf;13/08/13;http://www.agenziafarmaco.gov.it/sites/default/files/GU_Determina_689-2013.pdf
ORENCIA;EMEA/H/C/701/X/54;L04AA24;Abatacept;Bristol-Myers Squibb Pharma EEIG;lug-12;04-ott-12;30-nov-12;13-feb-13;Nuove confezioni;037989;04/09;292;14/03/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina2013_292_14032013_0.pdf;28/03/13;http://www.agenziafarmaco.gov.it/sites/default/files/GU292-2013sm.pdf
ORENCIA;EMEA/H/C/701;L04AA24;Abatacept;Bristol-Myers Squibb Pharma EEIG;mag-13;03-dic-13;31-gen-14;10-feb-14;Nuove confezioni;037989;10;568;09/06/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_568_09.06.2014_orencia.pdf;17/06/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_568-2014_GU.pdf
ORPHACOL;EMEA/H/C/1250;A05AA03 ;Cholic acid;Laboratoires CTRS (Cell Therapies Research & Services);apr-11;12-set-13;25-ott-13;06-nov-13;Prima autorizzazione;043028;01/03;___;___;In attesa che il titolare adempia agli obblighi previsti dalla Decisione Comunitaria (lettera del 14/11/13);___;___
OVALEAP;EMEA/H/C/2608;G03GA05 ;Follitropin alfa;Teva Pharma B.V.;lug-13;27-set-13;25-ott-13;06-nov-13;Generico / Equivalente / Biosimilare;043029;01/03;1139;12/12/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_1139.PDF;27/12/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_1139_GU.pdf
PANDEMIC INFLUENZA VACCINE H5N1 BAXTER;EMEA/H/C/1200/II/15;J07BB01 ;Pandemic influenza vaccine (H5N1 whole virion, Vero cell derived, inactivated);Baxter AG;ott-13;25-nov-13;28-dic-13;13-gen-14;Nuove confezioni;040569;02;88;29/01/2014;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_88NC.pdf;21/02/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2014_88_GU.pdf
PEGASYS;EMEA/H/C/395;L03AB11;Peginterferon alfa-2a;Roche Registration Limited ;gen-13;13-mar-13;26-apr-13;14-mag-13;Nuove confezioni;035683;17;580;17/06/2013;http://www.agenziafarmaco.gov.it/sites/default/files/Determinazione_580-2013.pdf;05/07/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013-580_0.pdf
PERJETA;EMEA/H/C/2547;L01XC13;Pertuzumab;Roche Registration Ltd;dic-12;13-dic-12;26-apr-13;10-apr-13;Prima autorizzazione;042682;01;518;27/05/2013;http://www.agenziafarmaco.gov.it/sites/default/files/Determinazione_518-2013.pdf;14/06/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013-518.pdf
PHEBURANE;EMEA/H/C/2500;A16AX03 ;Sodium phenylbutyrate;Lucane Pharma;feb-13;31-lug-13;30-ago-13;08-ott-13;Prima autorizzazione;042917;01;993;13/11/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_993_2013.pdf;28/11/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_993_GU.pdf
PICATO;EMEA/H/C/2275;D06BX02;Ingenol mebutate;Leo Pharma A/S;set-12;15-nov-12;28-dic-12;13-feb-13;Prima autorizzazione;042513;01/02;291;14/03/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina2013_291_14032013.pdf;29/03/13;http://www.agenziafarmaco.gov.it/sites/default/files/determina_291_2013_GU.pdf
PLEGRIDY ;EMEA/H/C/2827;L03AB13 ;peginterferon beta-1a;Biogen Idec Limited;mag-14;18-lug-14;29-ago-14;15-set-14;Prima autorizzazione;043527;01/06;1012;24/09/2014;http://www.agenziafarmaco.gov.it/sites/default/files/determina_NP_1012.pdf;14/10/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_n._1012-2014_GU.pdf
PLENADREN;EMEA/H/C/2185/IB/11/G;H02AB09;hydrocortisone;ViroPharma SPRL-BVBA;ND;20-nov-13;28-dic-13;13-gen-14;Nuove confezioni;042487;03/08;88;29/01/2014;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_88NC.pdf;21/02/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2014_88_GU.pdf
PRAVAFENIX;EMEA/H/C/1243/IB/4;C10BA03;Pravastatin and fenofibrate;LABORATOIRES SMB SA;N/A;29-ott-12;30-nov-12;13-feb-13;Nuove confezioni;042556;07;292;14/03/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina2013_292_14032013_0.pdf;28/03/13;http://www.agenziafarmaco.gov.it/sites/default/files/GU292-2013sm.pdf
PRAVAFENIX;EMEA/H/C/1243/IB/4;C10BA03;Pravastatin and fenofibrate;LABORATOIRES SMB SA;N/A;29-ott-12;30-nov-12;14-mag-13;Nuove confezioni;042556;07;589;21/06/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina_589.pdf;06/07/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013-589_0.pdf
PREGABALIN PFIZER;EMEA/H/C/3880;N03AX16 ;pregabalin;Pfizer Limited;feb-14;10-apr-14;29-mag-14;09-giu-14;Prima autorizzazione;043370;01/43;___;___;___;___;___
PREVENAR 13;EMEA/H/C/1104;J07AL02;Pneumococcus, purified polysaccharides antigen conjugated;Pfizer Limited;mar-13;09-lug-13;30-ago-13;27-set-13;Nuove confezioni;039550;7/11;887;14/10/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_NC_887.pdf;29/10/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_887_GU.pdf
PREZISTA;EMEA/H/C/707/X/41/G, EMEA/H/C/707/II/49;J05AE10 ;Darunavir;Janssen-Cilag International NV;lug-12;24-ott-12;30-nov-12;13-feb-13;Nuove confezioni;037634;06;292;14/03/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina2013_292_14032013_0.pdf;28/03/13;http://www.agenziafarmaco.gov.it/sites/default/files/GU292-2013sm.pdf
PREZISTA;EMEA/H/C/707/IB/50, EMEA/H/C/707/X/46;J05AE10 ;Darunavir;Janssen-Cilag International NV;ott-12;14-gen-13;22-feb-13;10-apr-13;Nuove confezioni;037634;07;517;27/05/2013;http://www.agenziafarmaco.gov.it/sites/default/files/Determinazione_517-2013.pdf;14/06/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013-517.pdf
PREZISTA;EMEA/H/C/707/WS/396;J05AE10 ;Darunavir;Janssen-Cilag International NV;mag-13;01-lug-13;30-ago-13;27-set-13;Nuove confezioni;037634;08;887;14/10/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_NC_887.pdf;29/10/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_887_GU.pdf
PROMETAX;EMEA/H/C/255;N06DA03;Rivastigmine;Novartis Europharm Ltd;nov-12;14-gen-13;pending;06-giu-13;Nuove confezioni;034318;27/30;___;___;In attesa che il titolare adempia agli obblighi previsti dalla Decisione Comunitaria (lettera del 12/06/13);___;___
PROVENGE;EMEA/H/C/2513;L03AX17 ;Autologous peripheral blood mononuclear cells activated with PAP-GM-CSF (Sipuleucel-T);Dendreon UK Limited;giu-13;06-set-13;25-ott-13;06-nov-13;Prima autorizzazione;043040;01;___;___;In attesa che il titolare adempia agli obblighi previsti dalla Decisione Comunitaria (lettera del 14/11/13);___;___
REFACTO AF;EMEA/H/C/232/II/109;B02BD02;Fattore VIII della coagulazione ricombinante   Moroctocog alfa;Pfizer Limited;set-12;24-ott-12;30-nov-12;13-feb-13;Nuove confezioni;034421;09;___;___;Non applicabile (concomitante provvedimento UP&R);___;___
RELVAR ELLIPTA;EMEA/H/C/2673;R03AK10 ;fluticasone furoate/vilanterol trifenatate;Glaxo Group Limited;set-13;13-nov-13;28-dic-13;13-gen-14;Prima autorizzazione;043154;01/06;86;29/01/2014;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_86NP.pdf;21/02/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2014_86_GU.pdf
REMSIMA;EMEA/H/C/2576;L04AB02 ;Infliximab;Celltrion Healthcare Hungary Kft.;giu-13;12-set-13;25-ott-13;08-ott-13;Generico / Equivalente / Biosimilare;042942;01;___;___;In attesa che il titolare adempia agli obblighi previsti dalla Decisione Comunitaria (lettera del 18/10/13);___;___
REVINTY ELLIPTA;EMEA/H/C/2745;R03AK10 ;fluticasone furoate / vilanterol trifenatate;Glaxo Group Ltd;mar-14;02-mag-14;27-giu-14;01-lug-14;Prima autorizzazione;043446;01/06;881;18/08/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_881_del_18.07.2014.pdf;29/08/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina2014_881.pdf
REVLIMID;EMEA/H/C/717/II/56;L04AX04 ;Lenalidomide;Celgene Europe Limited;apr-13;13-giu-13;30-ago-13;04-lug-13;Nuove confezioni;038016;07/08;___;___;Farmaco in 648;___;___
REVOLADE ;EMEA/H/C/1110/X/12/G;B02BX05 ;Eltrombopag;GlaxoSmithKline Trading Services Limited;lug-13;19-set-13;25-ott-13;06-nov-13;Nuove confezioni;039827;07/09;883;18/08/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_883_del_18.08.2014_0.pdf;29/08/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina2014_883.pdf
RIBAVIRINA MYLAN;EMEA/H/C/1185/IB/9/G, EMEA/H/C/1185/N/5;J05AB04;Ribavirin;Generics [UK] Limited;N/A;29-ott-12;30-nov-12;13-feb-13;Nuove confezioni;040750;05/11;___;___;Non applicabile (precedente provvedimento UP&R);___;___
RIENSO;EMEA/H/C/2215/IA/1/G, EMEA/H/C/2215/N/2;pending;Ferumoxytol;Takeda Global Research and Development Centre (Europe) Ltd;N/A;29-ott-12;30-nov-12;13-feb-13;Nuove confezioni;042509;03/04;292;14/03/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina2013_292_14032013_0.pdf;28/03/13;http://www.agenziafarmaco.gov.it/sites/default/files/GU292-2013sm.pdf
RILUZOLO ZENTIVA;EMEA/H/C/2622/N/47;N07XX02 ;Riluzolo;Aventis Pharma S.A.;NA;11-lug-14;29-ago-14;15-set-14;Nuove confezioni;042155;02/05;1019;26/09/2014;http://www.agenziafarmaco.gov.it/sites/default/files/determina_NC_1019.pdf;14/10/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_n._1019-2014_GU.pdf
RISTABEN;EMEA/H/C/1234/WS/558;A10BH01 ;sitagliptin;Merck Sharp & Dohme Limited;mag-14;19-ago-14;26-set-14;21-ott-14;Nuove confezioni;043563;19/24;1337;11/11/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_1337_del_11.11.2014_0.pdf;___;___
RIVASTIGMINA 3M HEALTH CARE LTD;EMEA/H/C/3824;N06DA03 ;rivastigmine;3M Health Care Limited;gen-14;03-apr-14;29-mag-14;09-giu-14;Generico / Equivalente / Biosimilare;043371;01/08;___;___;In attesa che il titolare adempia agli obblighi previsti dalla Decisione Comunitaria (lettera del 16/06/14);___;___
RIVASTIGMINA ACTAVIS;EMEA/H/C/2036;N06DA03;Rivastigmine;Actavis Group PTC ehf;feb-13;17-apr-13;31-mag-13;04-lug-13;Nuove confezioni;041280;17/24;785;12/09/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina_785_2013.pdf;23/09/13;http://www.agenziafarmaco.gov.it/sites/default/files/determina_2013_785_gu.pdf
ROACTEMRA ;EMEA/H/C/955/X/30;L04AC07 ;Tocilizumab;Roche Registration Limited;feb-14;03-apr-14;29-mag-14;01-lug-14;Nuove confezioni;038937;07;___;___;Non applicabile (precedente provvedimento UP&R);;
RYZODEG;EMEA/H/C/2499;pending;Insulin degludec/insulin aspart;Novo Nordisk A/S;ott-12;21-gen-13;22-feb-13;10-apr-13;Prima autorizzazione;042656;01/04;518;27/05/2013;http://www.agenziafarmaco.gov.it/sites/default/files/Determinazione_518-2013.pdf;14/06/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013-518.pdf
RYZODEG;EMEA/H/C/2499;pending;Insulin degludec/insulin aspart;Novo Nordisk A/S;N/A;23-apr-14;29-mag-14;09-giu-14;Nuove confezioni;042656;05/07/08;___;___;___;___;___
SABERVEL;EMEA/H/C/2510/IB/3/G, EMEA/H/C/2510/N/2;C09CA04;Irbesartan;Pharmathen S.A.;N/A;29-ott-12;30-nov-12;13-feb-13;Nuove confezioni;042538;07/09;292;14/03/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina2013_292_14032013_0.pdf;28/03/13;http://www.agenziafarmaco.gov.it/sites/default/files/GU292-2013sm.pdf
SELINCRO;EMEA/H/C/2583;N07BB ;Nalmefene;H.Lundbeck A/S;dic-12;13-dic-12;28-mar-13;10-apr-13;Prima autorizzazione;042683;01/05;518;27/05/2013;http://www.agenziafarmaco.gov.it/sites/default/files/Determinazione_518-2013_0.pdf;14/06/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013-518.pdf
SELINCRO;EMEA/H/C/2583;N07BB ;Nalmefene;H. Lundbeck A/S;NA;22-mag-14;27-giu-14;01-lug-14;Nuove confezioni;042683;06;828;31/07/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_828_del_31.07.2014.pdf;29/08/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina2014_828.pdf
SILDENAFIL RATIOPHARM ;EMEA/H/C/1080;G04BE03 ;Sildenafil;ratiopharm GmbH;N/A;09-dic-13;31-gen-14;10-feb-14;Nuove confezioni;042092;16/17;175;27/02/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_n._175_2014.pdf;17/03/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina2014_175_GU.pdf
SILDENAFIL RATIOPHARM ;EMEA/H/C/1080/R/35;G04BE03 ;Sildenafil;ratiopharm GmbH;lug-14;09-set-14;31-ott-14;10-nov-14;Nuove confezioni;042092;18;___;___;___;___;___
SILDENAFIL TEVA;EMEA/H/C/1073;G04BE03 ;sildenafil;Teva Pharma B.V. ;N/A;31-gen-14;28-feb-14;07-apr-14;Nuove confezioni;042088;19/20;391;16/04/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_391.pdf;29/04/14;"http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2014_391_GU.pdf
"
SIMBRINZA ;EMEA/H/C/3698;Pending;Brinzolamide e Brimonidine;Alcon Laboratories (UK) Ltd.;mag-14;18-lug-14;29-ago-14;15-set-14;Prima autorizzazione;043532;01/02;1012;24/09/2014;http://www.agenziafarmaco.gov.it/sites/default/files/determina_NP_1012.pdf;14/10/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_n._1012-2014_GU.pdf
SIMPONI;EMEA/H/C/992;L04AB06 ;Golimumab;Janssen Biologics B.V.;giu-13;03-set-13;25-ott-13;06-nov-13;Nuove confezioni;039541;05/08;___;___;In attesa che il titolare adempia agli obblighi previsti dalla Decisione Comunitaria (lettera del 14/11/13);___;___
SIRTURO ;EMEA/H/C/2614;J04A ;bedaquiline;Janssen-Cilag International NV ;dic-13;05-mar-14;25-apr-14;12-mag-14;Prima autorizzazione;043332;01;620;23/06/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_620_del_2014.pdf;11/07/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_620_2014_GU.pdf
SOMATROPIN BIOPARTNERS ;EMEA/H/C/2196;H01AC01 ;Somatropin;BioPartners GmbH;mag-13;05-ago-13;27-set-13;08-ott-13;Prima autorizzazione;042943;01/07;1049;20/11/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_1049_2013.pdf;06/12/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_1049_GU.pdf
SOVALDI;EMEA/H/C/2798;Pending;sofosbuvir;Gilead Sciences International Limited;nov-13;16-gen-14;28-feb-14;10-mar-14;Prima autorizzazione;043196;01/02;___;___;___;___;___
SPEDRA;EMEA/H/C/002581;PENDING;Avanafil;VIVUS BV;apr-13;13-giu-13;30-ago-13;27-set-13;Prima autorizzazione;042876;1/10;885;14/10/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_NP_885.pdf;30/10/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_885_GU.pdf
STAYVEER;EMEA/H/C/2644;C02KX01 ;Bosentan;Marklas Nederland B.V.;mar-13;24-giu-13;30-ago-13;08-ott-13;Prima autorizzazione;042926;01/02;___;___;In attesa che il titolare adempia agli obblighi previsti dalla Decisione Comunitaria (lettera del 18/10/13);___;___
STIVARGA;EMEA/H/C/2573;L01XE21 ;Regorafenib;Bayer Pharma AG;giu-13;26-ago-13;27-set-13;08-ott-13;Prima autorizzazione;042925;01/02;1049;20/11/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_1049_2013.pdf;06/12/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_1049_GU.pdf
STRIBILD;EMEA/H/C/2574;PENDING;elvitegravir / cobicistat / emtricitabine / tenofovir disoproxil (as fumarate);Gilead Sciences International Ltd.;mar-13;24-mag-13;28-giu-13;04-lug-13;Prima autorizzazione;042815;01/02;690;26/07/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina_690.pdf;12/08/13;http://www.agenziafarmaco.gov.it/sites/default/files/determina_690_GU.pdf
SYLVANT;EMEA/H/C/3708;pending;Siltuximab;Janssen-Cilag International NV ;mar-14;22-mag-14;27-giu-14;01-lug-14;Prima autorizzazione;043447;01/02;881;18/08/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_881_del_18.07.2014.pdf;29/08/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina2014_881.pdf
SYNAGIS ;EMEA/H/C/257/X/95;J06BB16 ;palivizumab;AbbVie Ltd;giu-14;22-ago-14;26-set-14;21-ott-14;Nuove confezioni;034529;3/4;1337;11/11/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_1337_del_11.11.2014_0.pdf;___;___
TAFINLAR;EMEA/H/C/2604;L01XE23 ;Dabrafenib;GlaxoSmithKline Trading Services Limited;giu-13;26-ago-13;27-set-13;08-ott-13;Prima autorizzazione;042923;01/04;1049;20/11/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_1049_2013.pdf;06/12/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_1049_GU.pdf
TECFIDERA;EMEA/H/C/2601;N07XX09 ;Dimethyl fumarate;Biogen Idec Ltd.;nov-13;30-gen-14;28-feb-14;10-mar-14;Prima autorizzazione;043217;01/02;339;01/04/2014;http://www.agenziafarmaco.gov.it/sites/default/files/determina_339NP.pdf___;23/04/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2014_n._339_GU.pdf
TELMISARTAN TEVA PHARMA;EMEA/H/C/2511/IA/2/G, EMEA/H/C/2511/IB/3/G;C09CA07;Telmisartan;Teva Pharma B.V.;N/A;29-ott-12;30-nov-12;13-feb-13;Nuove confezioni;042272;61/62;292;14/03/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina2013_292_14032013_0.pdf;28/03/13;http://www.agenziafarmaco.gov.it/sites/default/files/GU292-2013sm.pdf
TELMISARTAN TEVA PHARMA;EMEA/H/C/2511/IB/11;C09CA07;Telmisartan;Teva Pharma B.V.;N/A;06-giu-14;25-lug-14;15-set-14;Nuove confezioni;042272;63/65;1019;26/09/2014;http://www.agenziafarmaco.gov.it/sites/default/files/determina_NC_1019.pdf;14/10/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_n._1019-2014_GU.pdf
TEMOZOLOMIDE SUN;EMEA/H/C/2198/IB/1, EMEA/H/C/2198/IB/2/G;L01AX03;Temozolomide;Sun Pharmaceuticals Industries Europe B.V.;N/A;25-ott-12;30-nov-12;13-feb-13;Nuove confezioni;041333;13/24;___;___;Non applicabile (precedente provvedimento UP&R);___;___
TESAVEL;EMEA/H/C/910/WS/558;A10BH01 ;Sitagliptin;Merck Sharp & Dohme Limited;mag-14;18-lug-14;29-ago-14;15-set-14;Nuove confezioni;038448;19/24;1019;26/09/2014;http://www.agenziafarmaco.gov.it/sites/default/files/determina_NC_1019.pdf;14/10/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_n._1019-2014_GU.pdf
TEYSUNO;EMEA/H/C/1242;L01BC53;Tegafur, combinations (Tegafur / gimeracil / oteracil);Nordic Group BV;N/A;29-ott-12;30-nov-12;13-feb-13;Nuove confezioni;042291;05;292;14/03/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina2013_292_14032013.pdf;28/03/13;http://www.agenziafarmaco.gov.it/sites/default/files/determina_292_2013_GU.pdf
TIVICAY;EMEA/H/C/2753;J05AX12 ;dolutegravir;ViiV Healthcare UK Limited;nov-13;16-gen-14;28-feb-14;10-mar-14;Prima autorizzazione;043195;01/02;339;01/04/2014;__http://www.agenziafarmaco.gov.it/sites/default/files/determina_339NP.pdf_;23/04/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2014_n._339_GU.pdf
TOLUCOMBI;EMEA/H/C/2549;C09DA07;Telmisartan and diuretics;Krka, d. d., Novo mesto;gen-13;13-mar-13;26-apr-13;14-mag-13;Generico / Equivalente / Biosimilare;042715;01/30;579;17/06/2013;http://www.agenziafarmaco.gov.it/sites/default/files/Determinazione_579-2013.pdf;05/07/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013-579_0.pdf
TOVIAZ;EMEA/H/C/723/IAin/39/G;G04BD11;Fesoterodine;Pfizer Limited;N/A;25-ott-12;30-nov-12;13-feb-13;Nuove confezioni;038699;19/20;292;14/03/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina2013_292_14032013_0.pdf;28/03/13;http://www.agenziafarmaco.gov.it/sites/default/files/GU292-2013sm.pdf
TRANSLARNA;EMEA/H/C/2720;Pending;Ataluren;PTC Therapeutics, Limited;mag-14;31-lug-14;29-ago-14;15-set-14;Prima autorizzazione;043535;01/03;___;___;___;___;___
TRESIBA;EMEA/H/C/2498;pending;Insulin degludec;Novo Nordisk A/S;ott-12;21-gen-13;22-feb-13;10-apr-13;Prima autorizzazione;042658;01/09;688;26/07/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina_688.pdf;13/08/13;http://www.agenziafarmaco.gov.it/sites/default/files/determina_688_GU.pdf
TRIUMEQ ;EMEA/H/C/2754;J05AR13 ;dolutegravir / abacavir / lamivudine;ViiV Healthcare UK Limited;giu-14;01-set-14;31-ott-14;10-nov-14;Prima autorizzazione;043618;1/2;___;___;___;___;___
TYBOST;EMEA/H/C/2572;V03AX03 ;Cobicistat;Gilead Sciences International Limited;lug-13;19-set-13;25-ott-13;06-nov-13;Prima autorizzazione;043032;01/02;1138;12/12/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_1138.PDF;27/12/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_1138_GU.pdf
ULTIBRO BREEZHALER;EMEA/H/C/2679;R03AL04 ;Indacaterolo e glycopyrronium bromide;Novartis Europharm Limited;lug-13;19-set-13;25-ott-13;06-nov-13;Prima autorizzazione;043031;01/06;1138;12/12/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_1138.PDF;27/12/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_1138_GU.pdf
ULUNAR BREEZHALER;EMEA/H/C/3875;R03AL04 ;Indacaterolo e glycopyrronium bromide;Novartis Europharm Limited;feb-14;23-apr-14;29-mag-14;09-giu-14;Prima autorizzazione;043372;01/06;___;___;___;___;___
VELMETIA;EMEA/H/C/862/WS/559;A10BD07 ;Metformina e sitagliptin;Merck Sharp & Dohme Limited;NA;03-giu-14;25-lug-14;15-set-14;Nuove confezioni;038678;15/22;1019;26/09/2014;http://www.agenziafarmaco.gov.it/sites/default/files/determina_NC_1019.pdf;14/10/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_n._1019-2014_GU.pdf
VELPHORO ;EMEA/H/C/2705;V03AE05 ;mixture of polynuclear iron(iii)-oxyhydroxide, sucrose and starches;Vifor Fresenius Medical Care Renal Pharma France;giu-14;26-ago-14;26-set-14;21-ott-14;Prima autorizzazione;043564;1/4;1338;11/11/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_1338_del_11.11.2014_0.pdf;___;___
VENTAVIS  ;EMEA/H/C/474/X/43;B01AC11 ;Iloprost;Bayer Pharma AG;mag-14;18-lug-14;29-ago-14;15-set-14;Nuove confezioni;036019;9/10;1019;26/09/2014;http://www.agenziafarmaco.gov.it/sites/default/files/determina_NC_1019.pdf;14/10/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_n._1019-2014_GU.pdf
VEPACEL;EMEA/H/C/2089/II/2;J07BB01;Influenza, inactivated, whole virus;Baxter Innovations GmbH;N/A;04-ott-12;30-nov-12;13-feb-13;Nuove confezioni;042580;02;292;14/03/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina2013_292_14032013_0.pdf;28/03/13;http://www.agenziafarmaco.gov.it/sites/default/files/GU292-2013sm.pdf
VIAGRA;EMEA/H/C/202;G04BE03;Sildenafil;Pfizer Ltd.;feb-13;17-apr-13;31-mag-13;04-lug-13;Nuove confezioni;034076;20/23;689;26/07/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina_n.689_2013.pdf;13/08/13;http://www.agenziafarmaco.gov.it/sites/default/files/GU_Determina_689-2013.pdf
VIMIZIM;EMEA/H/C/2779;A16AB12 ;elosulfase alfa;BioMarin Europe Ltd;feb-14;28-apr-13;29-mag-14;09-giu-14;Prima autorizzazione;043377;01;___;___;In attesa che il titolare adempia agli obblighi previsti dalla Decisione Comunitaria (lettera del 16/06/14);___;___
VIMPAT;EMEA/H/C/863/R/0041;N03AX18 ;Lacosamide;UCB Pharma S.A.;mag-13;31-lug-13;30-ago-13;08-ott-13;Nuove confezioni;038919;20/23;994;13/11/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_994_2013.pdf;28/11/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_994_GU.pdf
VIPDOMET;EMEA/H/C/2654;A10BD13 ;Metformin e alogliptin;Takeda Pharma A/S;lug-13;19-set-13;25-ott-13;06-nov-13;Prima autorizzazione;043045;01/24;1138;12/12/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_1138.PDF;27/12/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_1138_GU.pdf
VIPIDIA;EMEA/H/C/2182;A10BH04 ;Alogliptin;Takeda Pharma A/S;lug-13;19-set-13;25-ott-13;06-nov-13;Prima autorizzazione;043051;01/27;1138;12/12/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_1138.PDF;27/12/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_1138_GU.pdf
VIREAD;EMEA/H/C/419/X/105/G, EMEA/H/C/419/II/115;J05AF07 - ;Tenofovir disoproxil;Gilead Sciences International Limited;set-12;22-nov-12;28-dic-12;13-feb-13;Nuove confezioni;035565;04/09;292;14/03/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina2013_292_14032013_0.pdf;28/03/13;http://www.agenziafarmaco.gov.it/sites/default/files/GU292-2013sm.pdf
VIREAD;EMEA/H/C/419/X/105/G, EMEA/H/C/419/II/115;J05AF07 - ;Tenofovir disoproxil;Gilead Sciences International Limited;set-12;22-nov-12;28-dic-12;12-mar-13;Nuove confezioni;035565;03;368;05/04/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina_368_05042013.pdf;06/05/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_368-2013_GU.pdf
VITEKTA;EMEA/H/C/2577;J05AX11 ;elvitegravir;Gilead Sciences International Limited;set-13;13-nov-13;28-dic-13;13-gen-14;Prima autorizzazione;043117;01/02;86;29/01/2014;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_86NP.pdf;21/02/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2014_86_GU.pdf
VIVANZA;EMEA/H/C/000488/X/0043;G04BE09;Vardenafil;Bayer Pharma AG;apr-13;27-giu-13;30-ago-13;27-set-13;Nuove confezioni;035735;16;887;14/10/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_NC_887.pdf;29/10/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_887_GU.pdf
VIZAMYL ;EA/H/C/2557;V09AX04 ;Flutemetamol (18F);GE Healthcare Ltd;giu-14;22-ago-14;26-set-14;21-ott-14;Prima autorizzazione;043562;1/2;___;___;___;___;___
VOKANAMET;EMEA/H/C/2656;A10BD16 ;liflozin / metformin hydrochloride;Janssen-Cilag International NV;mar-14;23-apr-14;29-mag-14;09-giu-14;Prima autorizzazione;043375;01/12;___;___;___;___;___
VONCENTO;EMEA/H/C/2493;B02BD06 ;Von Willebrand factor and coagulation factor VIII in combination;CSL Behring GmbH;mag-13;12-ago-13;27-set-13;08-ott-13;Prima autorizzazione;042939;01/4;427;18/04/2014;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_427_VONCENTO.PDF;19/05/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2014_427_GU.pdf
VORICONAZOLO ACCORD;EMEA/H/C/2669;J02AC03 ;Voriconazole;Accord Healthcare Ltd.;mar-13;16-mag-13;28-giu-13;04-lug-13;Generico / Equivalente / Biosimilare;042809;01/18;687;26/07/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina_687.pdf;13/08/13;http://www.agenziafarmaco.gov.it/sites/default/files/determina_687_GU.pdf
VOTUBIA;EMEA/H/C/2311/X/8/G;L01XE10 ;Everolimus;Novartis Europharm Limited;set-13;15-nov-13;28-dic-13;13-gen-14;Nuove confezioni;041397;09/15;88;29/01/2014;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_88NC.pdf;21/02/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2014_88_GU.pdf
VOTUBIA;EMEA/H/C/2311/R/15;L01XE10 ;Everolimus;Novartis Europharm Limited;apr-13;17-lug-13;30-ago-13;08-ott-13;Nuove confezioni;041397;08;994;13/11/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_994_2013.pdf;28/11/13;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_994_GU.pdf
XALKORI;EMEA/H/C/2489;L01XE16;Crizotinib;Pfizer Ltd;lug-12;23-ott-12;30-nov-12;09-gen-13;Prima autorizzazione;042549;01/04;___;___;Farmaco in 648;___;___
XARELTO;EMEA/H/C/944/II/30;B01AX06 ;Rivaroxaban;Bayer Pharma AG;giu-14;31-lug-14;29-ago-14;15-set-14;Nuove confezioni;038744;34/35;___;___;___;___;___
XARELTO 10MG, 15MG e 20 MG;EMEA/H/C/944;B01AX06;Rivaroxaban;Bayer Pharma AG;mar-13;22-mag-13;28-giu-13;04-lug-13;Nuove confezioni;038744;22/24;689;26/07/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina_n.689_2013.pdf;13/08/13;http://www.agenziafarmaco.gov.it/sites/default/files/GU_Determina_689-2013.pdf
XARELTO 2,5 MG;EMEA/H/C/944;B01AX06;Rivaroxaban;Bayer Pharma AG;mar-13;22-mag-13;28-giu-13;04-lug-13;Nuove confezioni;038744;25/33;776;30/08/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina_XARELTO_N.776.pdf;23/09/13;http://www.agenziafarmaco.gov.it/sites/default/files/determina_2013_776_gu.pdf
XELEVIA;EMEA/H/C/762/WS/558;A10BH01 ;Sitagliptin;Merck Sharp & Dohme Limited;mag-14;28-lug-14;29-ago-14;15-set-14;Nuove confezioni;037794;19/24;1019;26/09/2014;http://www.agenziafarmaco.gov.it/sites/default/files/determina_NC_1019.pdf;14/10/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_n._1019-2014_GU.pdf
XIGDUO;EMEA/H/C/2672;Pending;dapagliflozin/metformin;Bristol-Myers Squibb/AstraZeneca EEIG;nov-13;16-gen-14;28-feb-14;10-mar-14;Prima autorizzazione;043208;01/12;339;01/04/2014;http://www.agenziafarmaco.gov.it/sites/default/files/determina_339NP.pdf;23/04/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2014_n._339_GU.pdf
XOFIGO;EMEA/H/C/2653;V10XX03 ;Radium Ra 223 dichloride;Bayer Pharma AG;set-13;13-nov-13;28-dic-13;13-gen-14;Prima autorizzazione;043116;01;86;29/01/2014;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_86NP.pdf;21/02/14;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2014_86_GU.pdf
XOTERNA  BREEZHALER;EMEA/H/C/3755;R03AL04 ;Indacaterolo e glycopyrronium bromide;Novartis Europharm Limited;lug-13;19-set-13;25-ott-13;06-nov-13;Prima autorizzazione;043033;01/06;1138;12/12/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_1138.PDF;27/12/2013;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_1138_GU.pdf
XTANDI;EMEA/H/C/002639;PENDING;Enzalutamide;Astellas Pharma Europe B.V.;apr-13;21-giu-13;30-ago-13;27-set-13;Prima autorizzazione;042868;01;885;14/10/2013;http://www.agenziafarmaco.gov.it/sites/default/files/DETERMINA_NP_885.pdf;30/10/2013;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013_885_GU.pdf
XULTOPHY ;EMEA/H/C/2647;Pending;insulin degludec / liraglutide;Novo Nordisk A/S;lug-14;18-set-14;31-ott-14;10-nov-14;Prima autorizzazione;043619;1/4;___;___;___;___;___
ZALTRAP;EMEA/H/C/2532;L01XX;Aflibercept;Sanofi-Aventis groupe;nov-12;01-feb-13;28-mar-13;10-apr-13;Prima autorizzazione;042689;01/03;518;27/05/2013;http://www.agenziafarmaco.gov.it/sites/default/files/Determinazione_518-2013.pdf;14/06/2013;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2013-518.pdf
ZEBINIX;EMEA/H/C/988;N03AF04 ;eslicarbazepine acetate;BIAL - Portela & Ca, SA;nov-13;22-gen-14;28-feb-14;07-apr-14;Nuove confezioni;039910;21/23;391;16/04/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_391.pdf;29/04/2014;http://www.agenziafarmaco.gov.it/sites/default/files/Determina_2014_391_GU.pdf
ZOELY;EMEA/H/C/1213/IB/6/G, EMEA/H/C/1213/IB/7/G, EMEA/H/C/1213/N/3;G03AA14;Nomegestrol and estrogen;Theramex S.r.l.;N/A;29-ott-12;28-dic-12;13-feb-13;Nuove confezioni;041400;03/04;292;14/03/2013;http://www.agenziafarmaco.gov.it/sites/default/files/determina2013_292_14032013_0.pdf;28/03/2013;http://www.agenziafarmaco.gov.it/sites/default/files/GU292-2013sm.pdf
ZYDELIG ;EMEA/H/C/3843;L01XX47 ;idelalisib;Gilead Sciences International Limited;lug-14;18-set-14;31-ott-14;10-nov-14;Prima autorizzazione;043620;1/2;___;___;___;___;___
